REG-Convatec Group PLC Convatec Group PLC: Results of 2022 AGM – Update Statement

ConvaTecAnnouncement

23/09/2022 14:15

============

   Convatec Group PLC (CTEC)
   Convatec Group PLC: Results of 2022 AGM – Update Statement

   23-Sep-2022 / 14:00 GMT/BST
   Dissemination of a Regulatory Announcement, transmitted by EQS Group.
   The issuer is solely responsible for the content of this announcement.

   ══════════════════════════════════════════════════════════════════════════

   23 September 2022

                               Convatec Group Plc
                         ("Convatec" or "the Company")

                     Results of 2022 AGM – Update Statement

   While the Resolution to approve the Directors' Remuneration Report at the
   last AGM was passed, we acknowledge that a number of shareholders chose
   not to support this Resolution.

   Prior to the AGM the Remuneration Committee consulted extensively with
   shareholders and following the AGM, the Remuneration Committee Chair wrote
   to our largest shareholders who voted against the Resolution to understand
   their reasons and to offer further engagement.

   The Remuneration Committee is committed to positive engagement with
   shareholders and will be consulting further over the coming months in
   respect of the Company's forthcoming Remuneration Policy review.

    

    

   Enquiries 

   Analysts and Investors 

   Kate Postans, VP Investor Relations,
   Convatec                                                            +44
   (0)782 644 7807 

    1 ir@convatec.com 

    

   Media 

   Buchanan: Charles Ryland / Chris Lane              
                                                               +44 (0)207 466
   5000                                            

   Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92 

    

   About Convatec 
    

   Pioneering trusted medical solutions to improve the lives we touch:
   Convatec is a FTSE 250 global medical products and technologies company,
   focused on solutions for the management of chronic conditions, with
   leading positions in advanced wound care, ostomy care, continence and
   critical care, and infusion care. Group revenues in 2021 were over $2
   billion. With around 10,000 colleagues, we provide our products and
   services in over 100 countries, united by a promise to be forever caring.
   Our products provide a range of benefits, from infection prevention and
   protection of at-risk skin, to improved patient outcomes and reduced care
   costs. To learn more about Convatec, please visit
    2 http://www.convatecgroup.com

    

   ══════════════════════════════════════════════════════════════════════════

   ISIN:          GB00BD3VFW73
   Category Code: AGM
   TIDM:          CTEC
   LEI Code:      213800LS272L4FIDOH92
   Sequence No.:  189992
   EQS News ID:   1448703


    
   End of Announcement EQS News Service

   ══════════════════════════════════════════════════════════════════════════

    3 fncls.ssp?fn=show_t_gif&application_id=1448703&application_name=news&site_id=refinitiv2

References

   Visible links
   1. mailto:ir@convatec.com
   2. https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=26f8de477e9a42123589f91471356e0b&application_id=1448703&site_id=refinitiv2&application_name=news


============